SANTA MONICA, Calif., Dec. 8, 2010 /PRNewswire/ -- Derycz Scientific, Inc. (OTC Bulletin Board: DYSC), a company that is pioneering a fresh way of facilitating the flow of information from content publishers to enterprise customers and their constituents, today announced that its subsidiary Reprints Desk, Inc. has signed a direct agreement with the Massachusetts Medical Society for the electronic distribution of articles from the New England Journal of Medicine (NEJM). This agreement adds to Reprints Desk's direct distribution agreements covering the top three medical journals in the world -- New England Journal of Medicine, Journal of the American Medical Association (JAMA), and The Lancet from Elsevier -- based on the impact factor. Impact Factors, originally devised by Institute for Scientific Information (ISI) founder Eugene Garfield, are calculated each year for journals indexed in Thomson Reuter's Journal Citation Reports.
Reprints Desk is honored to be entrusted by NEJM to deliver their valuable content in this manner," said Jan Peterson, Derycz Scientific's Head of Publisher Relations. "Reprints Desk is able to provide our global customer base with ultra-rapid document delivery service because of our focus on publisher relationships, which enable us to deliver the majority of our articles within minutes."
Derycz Scientific's Reprints Desk, established in 2006, ranked first overall and in every category in the 2008 Document Delivery Best Practices and Vendor Scorecard by analyst and advisory firm Outsell, Inc., and earned a 97% customer satisfaction rating in Dun & Bradstreet's 2009 Open Ratings survey of existing Reprints Desk customers. Derycz Scientific's Reprints Desk is also a proud corporate sponsor of Room to Read, a non-profit that establishes libraries in developing nations in support of literacy and gender equality in education.
The New England Journal of Medicine (NEJM.org) is dedicated to bringing physicians the best research and key information at the intersection of biomedical science and clinical practice, and to presenting the information in an understandable and clinically useful format. A career companion for physicians, NEJM keeps practicing physicians informed on developments that are important to their patients and keeps them connected to both clinical science and the values of being a good physician.
NEJM employs a highly rigorous peer-review and editing process to evaluate manuscripts for scientific accuracy, novelty, and importance. The editors have set policies to ensure that authors disclose all relevant financial associations and that those financial associations do not influence published content. These factors contribute to NEJM's reputation as the "gold standard" for quality biomedical research and for the best practices in clinical medicine.
NEJM is the most widely read, cited, and influential general medical periodical in the world. As it evolves to meet the changing needs of its readers in the 21st century, it is committed to maintaining that reputation and integrity, while using innovative formats and technologies for new features and faster delivery and access.
About Derycz Scientific®
Derycz Scientific, Inc. develops companies, products, services and systems that facilitate the re-use of published content in a manner that helps organizations achieve their marketing, communication and research goals effectively and in compliance with copyright law and regulatory rules. Its subsidiary companies include Reprints Desk and Pools Press. Reprints Desk offers a one-stop solution for reprints, ePrints and single articles, and has delivered millions of articles worldwide. Reprints Desk is an innovator in content retrieval and ePrint delivery, and its services are designed to help make effective use of published articles in a copyright-compliant manner. Pools Press has excelled in the reprint market for more than 30 years. It provides professionally printed articles from medical and technical journals; prints booklets, catalogs, pamphlets, direct mail pieces, newsletters and all business stationery; and works with publishers who wish to outsource a portion of or all of their reprints business. For more information, please visit www.deryczscientific.com.
Certain matters discussed in this press release may be forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such matters involve risks and uncertainties that may cause actual results to differ materially, including the following: changes in economic conditions; general competitive factors; acceptance of the company's products in the market; the company's success in technology and product development; the company's ability to execute its business model and strategic plans; and all the risks and related information described from time to time in the company's filings with the Securities and Exchange Commission ("SEC"), including the financial statements and related information contained in the company's Annual Report on Form 10-K filed with the SEC. The company assumes no obligation to update the cautionary information in this release.
SOURCE Derycz Scientific, Inc.